Publication | Open Access

High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial

Renal FunctionMedicineRenal PathologyChronic Kidney DiseaseParathyroid HormoneParathyroid DiseasePlacebo-controlled TrialHigh-dose Cholecalciferol ReducesPharmacologyRenal PharmacologyNephrology